Does UnitedHealthcare Cover Contrave?
The verdict
Conditional on most plans
UnitedHealthcare (OptumRx) covers Contrave only where the plan has a weight-loss drug benefit. OptumRx handles weight-loss agents including Contrave on its AOM/BMI pathway — a separate track from diabetes GLP-1 coverage. Where the employer carves out AOM, Contrave is excluded. Standard Medicare Part D excludes it by law. Where covered, OptumRx requires BMI ≥30 (or ≥27 with comorbidity) plus a documented diet/behavioral program. CurAccess at approximately $99/month is the cash fallback.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with UnitedHealthcare using your member ID.
Key facts
OptumRx routes Contrave through its AOM/BMI pathway — separate from the diabetes GLP-1 track. A plan-level AOM benefit must be present; a diabetes benefit does not cover weight-loss-only drugs.
OptumRx PBM formulary management guidance
Medicare Part D excludes weight-loss agents by statute. UHC Medicare (OptumRx) cannot cover Contrave. The 2026 Bridge covers only injectable weight-loss GLP-1s.
CMS.gov Medicare Part D statutory exclusions
CurAccess (Currax) provides Contrave at approximately $99/month with free shipping — open to cash-paying patients including government-insured who do not bill their plan.
Currax Pharmaceuticals CurAccess program
Medicare vs. commercial coverage
Whether UnitedHealthcare covers Contrave depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
UHC Medicare Part D (OptumRx) excludes Contrave by federal statute. The 2026 GLP-1 Bridge does not cover Contrave (Bridge covers Wegovy, Foundayo, Zepbound KwikPen only). The manufacturer coupon excludes Medicare members. CurAccess (~$99/month cash) is available to government-insured patients who do not bill their plan.
Commercial / Employer
Group & marketplace plans
UHC commercial/employer plans (OptumRx) cover Contrave only where the employer group has purchased a weight-loss benefit. OptumRx routes Contrave requests through its AOM/BMI pathway — the same pathway used for Wegovy, Saxenda, and similar weight-loss agents, separate from UHC's diabetes GLP-1 track. ACA/individual plans often exclude AOM. UHC Community Plan (Medicaid) is state-dependent. Cells are representative composites; verify on OptumRx/UHC drug lookup.
The 5 boxes you must tick to get approved
Commercial plans that will consider Contrave require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
0 of 5 requirements selected. Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Contrave actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Retail approximately $619 (Drugs.com) to $753 (SingleCare) per month.
List price with no coverage — before any manufacturer savings card.
With coverage
Commercial coupon: as low as $0, maximum $199/month without coverage. Usable for UHC commercial and ACA members; excludes Medicare and Medicaid.
Typical monthly copay once prior authorization is approved.
Bridge program
CurAccess (Currax): approximately $99/month with free shipping. Open to cash-paying patients including government-insured who do not bill their plan. No generic for Contrave.
Reduced copay through the assistance program, where eligible.
All figures are estimates. Confirm via OptumRx or UHC's drug pricing tool.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Search OptumRx or UHC's formulary for Contrave
Visit UnitedHealthcare.com or OptumRx.com and look up 'Contrave' or 'naltrexone/bupropion' with your plan ID. Check whether the AOM benefit is included on your specific plan.
- 2
Confirm OptumRx's AOM pathway requirements with your provider
If your plan covers weight-loss drugs, your doctor must document BMI (≥30 or ≥27 with comorbidity) and behavioral/diet program enrollment for OptumRx's AOM prior auth. This is separate from the diabetes GLP-1 track.
- 3
If excluded, use CurAccess as the cash option
OptumRx cannot approve what a plan has excluded. If the plan lacks an AOM benefit, go directly to CurAccess at approximately $99/month. The commercial coupon is an additional option for UHC commercial/ACA members — compare both.
Options if UnitedHealthcare won't cover Contrave
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
CurAccess (Currax direct program)
Approximately $99/month cash with free shipping — the primary fallback for UHC members without AOM benefit coverage.
Generic phentermine
OptumRx may require a phentermine (or Contrave) trial before approving a weight-loss GLP-1 — so phentermine can be a gateway step. Schedule IV, short-term (~12 weeks), approximately $40 cash.
Compounded semaglutide or tirzepatide (via Curex)
Injectable GLP-1-based weight-management option requiring no insurance or prior auth. Not the same medication as Contrave. From $49/month.
These options are listed for information only — your own clinician decides what is appropriate for you.
Frequently Asked Questions
OptumRx splits GLP-1 and weight-loss drug coverage by indication. Trulicity (dulaglutide) is a diabetes drug — OptumRx routes it through its diabetes GLP-1 track, requiring a T2D diagnosis and metformin step. Contrave is a weight-loss-only drug — OptumRx routes it through its AOM/BMI pathway, requiring BMI ≥30 (or ≥27 with comorbidity) and a behavioral program. A plan must include an AOM benefit for Contrave to be covered; diabetes coverage does not automatically include weight-loss coverage.
No. Medicare Part D excludes weight-loss agents by federal statute. This applies to UHC's Part D plans administered through OptumRx. The 2026 GLP-1 Bridge does not include Contrave. The manufacturer coupon also excludes Medicare members. CurAccess at approximately $99/month is the operative cash option for UHC Medicare members.
The manufacturer coupon reduces cost to as low as $0 (maximum $199/month without coverage) for commercially insured UHC/ACA members — excludes Medicare and Medicaid. CurAccess is Currax's direct cash program at approximately $99/month with free shipping; it is open to all cash-paying patients, including government-insured who do not bill their plan. CurAccess is often the lower-cost option; compare before filling.
Possibly, in reverse order. Some OptumRx step-therapy policies require a trial of an oral AOM (such as phentermine or Contrave) before approving a weight-loss GLP-1 like Wegovy — so phentermine may be required as a gateway before a GLP-1, not before Contrave. Whether Contrave itself requires a phentermine step varies by specific UHC plan; verify on OptumRx.
UHC Community Plan administers Medicaid in multiple states; anti-obesity drug coverage is state-determined. Some states' Medicaid PDLs exclude AOM; others may cover certain agents. There is no uniform UHC Community Plan answer — check your state's Medicaid PDL or contact UHC Community Plan for your state.
Related Articles
Does Aetna Cover Vyvanse? 2026 CVS Caremark Formulary
Aetna covers Vyvanse via CVS Caremark — generic lisdexamfetamine preferred, brand non-preferred. 70 mg/day QL per Policy 5.60.024; age-22 PA required.
Read moreDoes Aetna Cover Prolia? CVS Caremark Medical Benefit | Curex
Aetna covers Prolia under the medical benefit with PA — a q6-month clinic injection, not Part D. Jubbonti biosimilar now preferred on CVS Caremark.
Read moreDoes Anthem Cover Adderall? 2026 Coverage Guide | Curex
Anthem covers Adderall through CarelonRx — generic preferred, brand non-preferred. Step therapy may apply on some plans. Verify your Anthem plan.
Read moreDoes Anthem Cover Contrave? 2026 Brand Coverage Guide | Curex
Anthem covers Contrave only if your plan has a weight-loss benefit. Many plans carve it out. CurAccess ~$99/mo is often the fastest path.
Read moreDoes Aetna Cover Contrave? 2026 CVS Caremark Guide | Curex
Aetna (CVS Caremark) often excludes Contrave under AOM carve-outs. Where covered, CVS BMI prior auth applies. Medicare bars it by law. CurAccess ~$99/mo.
Read moreDoes Aetna Cover Forteo? 2026 Coverage Guide
Aetna (CVS) often excludes brand Forteo in favor of generic teriparatide or Bonsity. Teriparatide is covered with PA and bisphosphonate step therapy. 2026.
Read moreA weight-loss alternative that skips insurance and prior auth
You just saw how tangled Contrave coverage can get — auto-rejections, prior authorization, and high cash prices. Curex compounded semaglutide: $199/month equivalent prepaid annually ($2,388 upfront), or $299/month paid monthly. Compounded tirzepatide: $299/month equivalent prepaid annually ($3,588 upfront), or $399/month paid monthly. Commercial rates as of 2026-10-12; compounded products are not FDA-approved and clinical eligibility must be assessed. Curex compounded medications are not the same as Contrave. No insurance or prior authorization required; prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Contrave and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with UnitedHealthcare before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Contrave and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.